340 related articles for article (PubMed ID: 8800740)
1. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
Su H; Chang JC; Xu SM; Kan YW
Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
4. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir.
Macri P; Gordon JW
Hum Gene Ther; 1994 Feb; 5(2):175-82. PubMed ID: 7514448
[TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
[TBL] [Abstract][Full Text] [Related]
7. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Su H; Lu R; Chang JC; Kan YW
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13891-6. PubMed ID: 9391123
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
12. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
[TBL] [Abstract][Full Text] [Related]
13. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
Gao Ding Cheng ; An W; Dai J
Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
[TBL] [Abstract][Full Text] [Related]
17. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
Qian C; Bilbao R; Bruña O; Prieto J
Hepatology; 1995 Jul; 22(1):118-23. PubMed ID: 7601402
[TBL] [Abstract][Full Text] [Related]
18. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells.
He P; Tang ZY; Ye SL; Liu BB; Liu YK
J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
